HHS funds Ebola vaccine production for another year
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response will provide $23 million for Merck to produce additional doses of its investigational Ebola vaccine over the next year as part of the international response to the outbreak in the Democratic Republic of the Congo, and for domestic biodefense preparedness. Health officials in the DRC have vaccinated more than 192,000 high-risk contacts of infected people with the investigational vaccine, which has shown effectiveness against Ebola. ASPR’s Biomedical Advanced Research and Development Authority continues to work with Merck to advance development of the vaccine for licensure by the Food and Drug Administration.
Related News Articles
Headline
As a precaution in response to the recent Ebola outbreak in Uganda, the Centers for Disease Control and Prevention and Department of Homeland Security Customs…
Headline
The Centers for Disease Control and Prevention today issued an advisory to remind U.S. clinicians of best practices for evaluating patients for suspected Ebola…
Headline
The Centers for Disease Control and Prevention today joined the global public health community in marking the end of the Ebola outbreak in the Democratic…
Headline
With Ebola outbreaks in the Democratic Republic of the Congo and Guinea, the Centers for Disease Control and Prevention is reminding U.S. health care personnel…
Headline
Health officials in Guinea Sunday declared an Ebola outbreak in the nation’s southeastern N’Zerekore prefecture after confirming three cases in the rural…
Headline
The Centers for Disease Control and Prevention today joined the global public health community in marking the end of the Ebola outbreak in the Democratic…